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ABSTRACT
Introduction: National Health Service hospitals and
government agencies are increasingly using mortality
rates to monitor the quality of inpatient care. Mortality
and Morbidity (M&M) meetings, established to review
deaths as part of professional learning, have the
potential to provide hospital boards with the assurance
that patients are not dying as a consequence of unsafe
clinical practices. This paper examines whether and
how these meetings can contribute to the governance
of patient safety.
Methods: To understand the arrangement and role of
M&M meetings in an English hospital, non-participant
observations of meetings (n¼9) and semistructured
interviewswithmeetingchairs(n¼19)werecarriedout.
Following this, a structured mortality review process
was codesigned and introduced into three clinical
specialties over 12 months. A qualitative approach of
observations (n¼30) and interviews (n¼40) was used
to examine the impact on meetings and on frontline
clinicians, managers and board members.
Findings: The initial study of M&M meetings showed
a considerable variation in the way deaths were
reviewed and a lack of integration of these meetings
into the hospital’s governance framework. The
introduction of the standardised mortality review
process strengthened these processes. Clinicians
supported its inclusion into M&M meetings and
managers and board members saw that a standardised
trust-wide process offered greater levels of assurance.
Conclusion: M&M meetings already exist in many
healthcare organisations and provide a governance
resource that is underutilised. They can improve
accountability of mortality data and support quality
improvement without compromising professional
learning, especially when facilitated by a standardised
mortality review process.
INTRODUCTION
In recent years, there has been an increasing
international interest in using mortality rates
to monitor the quality of hospital care.
1 2
Concern about patient safety and scrutiny of
mortality rates intensiﬁed in the UK with the
extensive coverage of investigations into
National Health Service (NHS) hospital fail-
ures and the Dr Foster report with its patient
safety rating for NHS trusts.
34As a conse-
quence, boards of healthcare organisations
now require assurance that the care they
provide is safe and that patients are not dying
through failure of their services. Many trusts
include mortality rates in their performance
scorecards or dashboards and actively engage
with national patient safety improvement
initiatives, such as Patient Safety First and
Safer Patient Initiative, to reduce mortality
rates.
56
A forum that has traditionally reviewed in-
hospital deaths is the long-standing Mortality
and Morbidity (M&M) meeting established
by surgeons to further professional educa-
tion. In regularly reviewing deaths and
complications, these meetings have the
potential to provide accountability and the
necessary improvement measures required
for patient safety as well as professional
learning. How effective they are in fulﬁlling
these additional roles remains unexplored.
In many countries, M&M meetings are
embedded within the medical curriculum for
doctors in training.
7 Junior doctors present
cases to other doctors for reﬂection on
diagnostic or treatment decision-making, and
in return they receive clinicopathological
wisdom and learn presentation skills. In the
past, the brief discussions between the clini-
cians about the causes of death were thought
to be effective peer review and an adequate
means of changing practice.
89Little atten-
tion was paid to analysing the causes of
deaths for quality improvement.
10 11 Studies
have shown that for M&M meetings to facili-
tate improvement and be more than a forum
for peer review, they need to be structured and
systematic in reviewing and discussing deaths,
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Original researchdirecting discussions towards improving system and
process variations.
12e14 Studies recommended that to
support this, junior doctors’ training should include more
focus on systematic process change and less on medical
error in M&M meetings.
15e17
Historically, M&M meetings have been led and
attended only by the medical profession and have
remained autonomous, with knowledge not being avail-
able or shared with other professions or across the wider
hospital governance framework. This ‘silo’ working has
led to a lack of organisational learning and account-
ability.
18 Increasingly hospitals are beginning to inte-
grate M&M meetings into their governance processes, by
making them mandatory and more accountable for
reviewing deaths and taking corrective action should
adverse events arise.
19e21 To support this, the US Agency
for Healthcare Research and Quality has produced
web-based guidance for case analysis.
22
Traditionally, adverse outcomes discussed at M&M
meetings have been attributed to individual competence
in treating patients rather than the system or process
failures involved with the care.
11 23 Although both
contribute to errors, the focus on individuals has led
clinicians to fear embarrassment and loss of reputation,
making them reluctant to speak openly about errors at
meetings.
24 25 This defensive behaviour is thought to be
counterproductive to eliminating adverse events and
assuring safe care.
26 27
In light of this evidence we wanted to see whether and
how M&M meetings in an English teaching hospital
could facilitate quality improvement, be accountable and
provide assurance within the organisation’s governance
processes. Using a structured mortality review process as
a facilitating mechanism, we wanted to assess what
impact this would have on the original focus of the
meetings and on professional learning; to explore how
hospital staff viewed the changes; and evaluate the
potential that a different format of M&M meeting could
offer the organisation.
METHODS
Setting
The participating organisation was an English NHS
teaching hospital offering specialist tertiary services in
addition to general and surgical care. The study was
carried out in close collaboration with the hospital to
inform and support other strategies for reducing
mortality rates. The single case study allowed us to study
both horizontally (ie, across divisions) and vertically (up
and down the managerial and professional hierarchies)
within the organisation and this approach allowed us to
make analytic generalisations rather than statistical
ones.
28
Initial assessment
During 2009, we studied the characteristics and
processes of all the hospital M&M meetings and their
position within the governance framework using non-
participant observations at meetings (n¼9) and
semistructured interviews with meeting chairs and
governance managers (n¼19). The results showed
considerable variation in meeting structure, format and
case presentations, conﬁrming the ﬁndings from
previous studies. We found that the responsibility for
managing these meetings was devolved to clinical groups
and as a consequence they had developed indepen-
dently and in individual ways. There was no formal
reporting structure from these meetings into the wider
hospital governance to inform or assure the board that
deaths were not occurring as a result of unsafe care.
Following this we codeveloped a standardised mortality
review form and database with hospital staff, based on
recommendations in the literature and drawing on the
method of examining death used by the National
Conﬁdential Enquiry into Patient Outcome and Death
and the Scottish Audit of Surgical Mortality.
29e32 The
review form focused on whether the death was avoidable;
on issues arising from the care of the patient; and on
whether these could have contributed to the patient’s
death. It recorded where actions were necessary to
address any problems; whether an adverse incident
report was needed; and who was going to take any actions
forward (Mortality review form: Appendix 1, web only).
We developed and piloted the review form and database
which were then introduced into three clinical specialties
selected purposively for their patient cohort. This
process was carried out from January to December 2010
during which time we studied whether and how this
standardised mortality review process supported M&M
meetings to contribute to wider governance processes.
Participants
Five care groups across two divisions agreed to participate
in the study. Three care groups agreed to adopt a stand-
ardised mortality review process, two from a general
medical division and one from a specialist division. One
group in each division agreed to be a study control and
not implement the review process but participate in the
evaluation process. The two clinical divisions were
selectedtoparticipatebecausetheyregularlyexperienced
high numbers of deaths albeit for contrasting reasons.
Patients admitted to the general medical division had
a range of complex medical problems and multiple
comorbidities, were often frail and elderly and had
numerous possible causes of death. In contrast, patients
admittedintotheseconddivision,whichofferedspecialist
tertiaryservices,hadanarrowerrangeofspecialty-speciﬁc
causes of death, such as acute or end-stage organ failure.
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We used qualitative methods, interviews and observations
to understand how and whether the standard mortality
review process was or was not used, and how and
whether it supported M&M meetings in contributing to
governance.
Forty semistructured interviews were carried out by the
researcher (JH), including frontline staff (n¼32) and at
senior executive level (n¼8). (Interview schedule:
Appendix 2, web only). Participants were recruited with
the aim of acquiring a broad sample across professional
and occupational groups (Sampling matrix: Appendix 3,
web only). Interviews were carried out with Chairs of
M&M meetings (n¼5) as well as a range of consultants
(n¼6), junior doctors (n¼6), nursing staff (n¼7) who
attended the meetings, and some who were not invited,
to capture a wide range of experiences and views.
Managers and senior clinicians (n¼8), senior executives
and board members (n¼8) were selected because of
their governance role.
Interviewees were provided with study details when
they were invited to participate and were assured of
anonymity and conﬁdentiality. Consent to participating
and being recorded was obtained at the start of the
interview. Interviews lasted approximately 45 min.
Frontline staff interviewees were asked to identify the
role and format of M&M meetings; the importance of
quality improvement in making care safer; views about
the introduction of the review form and process; and the
governance of M&M meeting outcomes and account-
ability. Senior executives were asked what patient safety
data they currently received; the role that M&M meetings
played in providing that data; and how they perceived
the potential for a standardised process for reviewing
deaths in the hospital governance of patient safety.
In addition to the interviews, we used non-participant
observations at M&M (n¼26) and governance (n¼4)
meetings to provide background and context to the
interviewees’ comments. Consent for these was obtained
prior to commencing the data collection.
Data analysis
Observations were organised in Microsoft Excel.
Data from interviews were dual coded (JH and RW),
generating inductive and deductive themes, which were
agreed with a third researcher (NF) who read a sample
of transcripts. Data were organised and analysed using
NVivo 9 software.
FINDINGS
Two of the three specialties implemented the review
process throughout the study. The remaining specialty
helped with the development of the process but
refrained from testing the ﬁnal version. We present our
ﬁndings under the following three main headings: how
M&M meetings contributed to the governance of patient
safety within the hospital; how M&M meetings provided
a resource for learning and accountability; and what
impact the standardised review process had on both
activities.
THE CONTRIBUTION OF M&M MEETINGS TO THE
GOVERNANCE OF MORTALITY DATA
During the study, changes occurred in the governance of
mortality data at both trust and divisional levels of the
organisation as shown in ﬁgure 1. The left hand side of
the ﬁgure outlines the prestudy governance processes
for mortality data within the general medical division
and hospital and shows no upward reporting from divi-
sions to the hospital board and only informal cascading
of information down to frontline staff. The right hand
side shows the changes to governance introduced during
the course of the study.
A monthly high-level trust safety committee was
established to monitor externally published risk adjusted
mortality rates, investigate outliers identiﬁed by the
national regulator (the Care Quality Commission) and
receive 6-monthly divisional reports from M&M meet-
ings. It provided quarterly reports and assurance to
a quality subcommittee of the board. M&M meetings
within each division began reporting quarterly to the
divisional risk and governance committee, using
outcome measures produced from the standardised
review process. Improvement measures determined by
the M&M meetings were communicated to the frontline
staff through newly established ward-based specialty
governance and clinical management meetings. This
strengthening of divisional and hospital governance
arrangements may have been shaped in part by partici-
pation in, and feedback from, the study and a greater
awareness of the potential of M&M meetings to
contribute to governance.
All interviewees agreed that senior executives and
board members should be accountable for the safety of
patient care, especially when ‘things went wrong’, and
that reporting outcomes from M&M meetings to a trust
committee necessary. Illustrative interview quotes are
shown in box 1.
M&M participants viewed reporting to this Safety
Monitoring Committee as acceptable provided that the
environment was non-judgemental and understanding
of the case mix of their patients. Some clinicians and
managers appreciated the committee’s focus on data
while others wished for an opportunity to share learning
from other specialties, escalate unresolved issues and
receive support for change. This was contrary to the
578 BMJ Qual Saf 2012;21:576e585. doi:10.1136/bmjqs-2011-000603
Original researchviews of two senior executives who thought the role of
the committee was to monitor mortality rates, and that it
was the divisions’ responsibility to address quality and
safety issues.
M&M MEETINGS AS A RESOURCE FOR LEARNING,
IMPROVEMENT AND ACCOUNTABILITY
Observations of M&M meetings during January to
December 2010 showed considerable variation in the
structure, organisation and the process of reviewing
deaths as shown in tables 1 and 2. Responsibility for the
meetings was devolved to the specialties which had led
them to be non-standard and autonomous.
Meeting frequency
Clinical staff found weekly meetings helpful as the cases
were still fresh in their minds and the small number
allowed time for indepth discussion. However, the
chair of a meeting that met monthly suggested that
weekly meetings were less ‘special’ and would lose their
impact.
Figure 1 Changes to the
governance of mortality data
during the study.
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To encourage attendance, meetings were held at
lunchtime or during working hours as part of the
department’s education programme. One specialty held
their M&M review as part of a larger management
meeting that considered adverse incidents, complaints
and other ‘bad bits’ of the service. Incorporating
mortality reviews had the beneﬁt of integrating and
addressing all risk issues together, especially as it had ‘all
the right people round the table’ to achieve changes. It
reduced the number of meetings that clinicians with
managerial responsibilities had to attend but had the
disadvantage of not being open to all clinical staff.
The various ways in which M&M meetings reviewed
deaths is summarised in table 2. One control group
M&M meeting had already identiﬁed a need for a struc-
tured approach to their meetings and developed its own
system for categorising deaths. However, this system did
not identify the speciﬁc failures in care or action needed
to address them.
Case presentations
Generally, junior doctors were tasked with reviewing
deaths prior to meetings and presenting a summary of
each case at the meetings. In one instance, 40 cases were
presented in an hour and was ‘mind-numbingly boring’
according to one clinician. There was no time for
indepth discussions making the review a tick box cere-
mony with errors liable to be ‘swept under the table’. As
Box 1 The contribution of Mortality and Morbidity
meetings to the governance of mortality data
‘Obviously, it’s very important for the trust to know what’s
going on mortality-wise across the entire trust. And actually
I don’t think you can have meetings that are about such
a signiﬁcant area of care without that going to a higher
group of people. It’s all very well to say yes well we’ve got
mortality meetings in all of the divisions and they’re all going
ﬁne, but how does anybody know? . Because at the end of
the day they’re going to be the ones who are answering the
phone when the press sort of ring up and say ah we hear
that your standardised mortality ratio is through the roof!’
(Consultant).
‘I think that information from these meetings can provide
assurance that we don’t have excess deaths. It helps us to
pre-empt problems perhaps before we are alerted. By
looking at morbidity cases we can also try to avoid problems
before they lead to a fatality.’ (Chair, Safety Monitoring
Committee).
‘I think that it’s really important to . know that we have
learned from the experience, and so how you capture that
and reassure management that we won’t make the same
mistake again is really important..’ (Board member).
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Original researchpeer review was also important to clinicians, many
felt that all deaths should be presented to a wide audi-
ence. Achieving a balance between scrutinising all
deaths by more than one person, and selecting and
discussing avoidable deaths in depth, appeared to be
challenging.
Participation and culture
Both doctors and nurses reported that it was important
to know which cases were going to be discussed at
meetings. They wanted to familiarise themselves with the
relevant case details to ‘defend’ any course of action that
they had, or had not taken and for nurses especially, to
give them the conﬁdence to participate. All interviewees
stressed that M&M meetings should be blame-free to
facilitate improvement and accountability, although
some were not sure that this was true of their meetings.
One control group had made a deliberate decision to
develop a safe and non-critical environment before
considering any other aspect of the meeting.
Accountability
All the participants saw learning and improvement in
care as the purpose of M&M meetings and an essential
part of the clinical activity. Many saw them as having an
additional governance role as shown in box 2. There
were no reports that the educational and learning role of
the M&M meeting was compromised by a greater focus
on accountability.
THE IMPACT OF THE STANDARDISED MORTALITY REVIEW
PROCESS
Improved structure to meetings
Case reviewers liked how the standardised process
directed the line of questioning and made it easier to
extract the relevant information from case notes. Some
thought it was helpful as a teaching aid for junior
doctors. It highlighted and captured areas of concern
and helped to focus and structure the meeting: ‘helps
stop the rambling’. Many thought this was what was
needed in their meetings, as described in box 3.
Improved case review
The review process brought standardisation to the
examination of deaths and provided a framework
that could be applied to patient deaths in different
circumstances. It also provided an assurance that all
deaths were reviewed in the same way, a fact that board
members viewed positively. It gave the meetings more
signiﬁcance and made them ‘ofﬁcial’, reported one
person, ‘not just a paper exercise’. To maintain trans-
parency in meetings clinicians suggested that the review
form should be completed openly in the meeting.
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Original researchImproved records
The electronic record of the standardised mortality
review facilitated easier reporting and the identiﬁcation
of themes of issues over time. Clinicians spoke of its
capacity to formalise ‘organisational memory’, those
issues that arose infrequently and were only remem-
bered by long-standing members of staff. Actions needed
and assigned were more formally recorded, and in doing
so improved the likelihood of corrective measures being
undertaken. Equally important was the paper trail it
provided of how problems were addressed and practice
had changed.
Improved reporting and governance
Chairs and managers of the participating groups were
especially positive about the support the process offered
in producing performance reports for the trust Safety
Monitoring Committee. M&M meeting outcomesdthe
number of avoidable deaths, contributory factors and
actions taken to address any quality issuesdwere
included in their twice-yearly report and were later
developed into a standard reporting template by the
committee.
One of the intervention groups in the general medical
division identiﬁed a continuing problem with care which
was identiﬁed through a more structured mortality
review and addressed through an improved governance
structure. This is outlined in box 4.
Standardised process
Many clinicians, and especially board members, saw the
beneﬁt of having a standardised process across the
hospital to provide reassurance that all deaths were being
reviewed in the same way. The majority of those inter-
viewed wanted to see the review process extended to all
hospital M&M meetings. Some participants of the control
group M&M meetings, who had no experience of using
the process, felt that if it was rigorously completed, the
data would provide ‘clear performance metrics which
could be hugely valuable to the organisation’.
Concerns
There were a few less-positive comments from staff who
had not experienced the review process ﬁrst-hand. The
specialty that decided not to continue testing the study
review felt it would not advance their own process and
might limit the openness of the discussion, thus jeopard-
ising the ‘fragile culture’ of their meeting.
Some meeting participants expressed concern that
completing the review might become the focus of the
meeting rather than it being an aid to direct discussion.
Extra administrative support might also be needed.
Others suggested that specialties might wish to add
specialty-speciﬁc questions to the core template. Overall,
the concerns were outweighed by support for the process.
DISCUSSION
M&M meetings are an established part of medical
education and have existed for decades as forums for
doctors to review and present cases for biomedical
exploration. Their potential for quality improvement
depends on them being more structured and reviewing
deaths in a more systematic way. Changes to the
curriculum of junior doctors’ professional education
have done much to promote this.
24 33 34 Studies have
also shown how specialty or departmental M&M
Box 2 Mortality and Morbidity (M&M) meetings as
a resource for learning and accountability
‘I think the potential for them (M&M meetings) is absolutely
massive. I think if we have a culture of openness and
discussing these cases that are very difﬁcult in a very frank
robust way, and junior doctors and hopefully other staff
come to that and see that discussion, take (learning) away
with them, then I think that’s very powerful. And I think that if
we’re able to look at trends and patterns, then you can
also use that to inﬂuence policy or practice within the
division and within our wards and within our daily work.’
(Consultant).
‘In terms of reporting, I think . the Trust should know
exactly what is happening just as we should as clinicians’
(Chair, M&M meeting).
‘Everything should be transparent; what you are doing well
and what can be improved. If there are failings in the system
it should be readily available for board members.’ (Junior
doctor).
‘I think the big driver (for M&M meetings) would be about
improving patient outcomes.and linking it to the gover-
nance agenda, patient safety and patient experience and
that would be how I, and ward managers, should be
engaged in the process.’ (Nurse).
‘I guess if I look back I kind of wonder how on earth we
thought we had assurance of any description before we
started having robust M&Ms. I guess the reality is we didn’t
question too hard and had we questioned we’d have said no
we didn’t have any assurance. So they have a very impor-
tant role.’ (Senior manager).
Box 3 The impact of the standardised process on
Mortality and Morbidity meetings
‘I think they’ve become much more structured, and again
that’s been partly helped by the fact that we have a form
that actually provides a framework. I think without that
things become very woolly; people can kind of get bogged
down in looking at the micro aspects of morbidity and
mortality, and not necessarily the bigger picture.’
(Manager).
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reviews.
14 23 35 Our ﬁndings build on these and show
how M&M meetings can be integrated across the whole
hospital and contribute to the accountability for deaths
and governance of patient safety. Meetings that adopt
a standardised and systematic review process can focus
on systems and process failures; provide a record of
meeting outcomes and follow-up actions taken to
address failures; and facilitate the reporting of meeting
outcomes and assurance to the board.
We had anticipated that there might be greater resis-
tance from clinicians, who would want to maintain their
autonomy and not want to codify and share sensitive
data.
36 37 Our ﬁndings show considerable support from
them for both the standardised review process and the
wider governance role of M&M meetings. There may be
several reasons for a greater acceptance than expected.
Health professionals are expected to take responsibility
for governance of their own clinical practice and are
increasingly aware that hospitals are being monitored for
the quality of their care.
38 Many are being co-opted into
managerial roles such as clinical directors, medical
directors and chairs of governance committees and are
accountable for the governance of quality and safety
data.
36 39 This additional managerial responsibility
encourages clinicians to value systems that make the
provision of governance data easier.
The standard review process was generally accepted
because it met with clinicians’ requirements to capture
the tacit nature of case context and complexity.
18 26
Unlike many checklists it was adapted to their particular
contextual needs which gave them ownership.
40 Close
collaboration during its development also helped to
increase engagement and was seen less as a top-down
imposition.
41 42 Health professionals welcomed the focus
on systems and process failures and away from individual
competence, while senior executives and board members
appreciated the standardisation and safety monitoring
that the process supported.
43 Suggestions for an M&M
meeting review process that facilitates both learning and
assurance, based on our ﬁndings, are listed in box 5.
Although this is a single case study, personal commu-
nications with medical directors of four other NHS trusts
championing patient safety helped place our ﬁndings
into context. As with our case study, responsibility for
M&M meetings in these hospitals had previously been
devolved to clinicians and provided no assurance that
deaths were being reviewed in a systematic and rigorous
way. Outcomes from meetings were neither standardised
nor integrated into the hospital governance. In the
smaller hospitals, there was an increased focus on
reviewing and following up deaths but this was carried
Box 4 An example of a change in practice in the division
with improved governance
At a monthly departmental Mortality and Morbidity (M&M)
meeting, all 22 deaths from the previous month were
presented. These cases had been reviewed by two junior
doctors in consultation with the M&M meeting chair. The
junior doctors presented a summary of each case on
a single PowerPoint slide, describing clinical details and
causes of death. In four of the 22 cases, where the patients
were not expected to die, the meeting chair led a greater
examination and discussion. In one of these cases, an
acutely ill patient admitted to a medical ward had not
received the appropriate timely specialist input despite
a referral having been made. The M&M meeting agreed that
this omission constituted poor clinical care which potentially
contributed to the death. ‘Process issues and communica-
tion’ were attributed to the lack of response to the referral.
The case was also reviewed in the corresponding specialist
M&M meeting.
Action
1. Specialty consultant invited to the next M&M meeting for
an open discussion.
2. Referral guidelines to be produced jointly by the two
departments.
Problem repeated
1. Failure to get prompt specialist input on a further
occasion.
Action
1. Chair raised the issue at a quarterly divisional M&M
meeting: clinical director advised specialist divisions of
the need for compliance with new referral guidance.
2. Chair reported problem in his 6-monthly feedback to the
trust Safety Monitoring Committee for hospital-wide
compliance with the referral guidance.
Box 5 Suggestions for using Mortality and Morbidity
(M&M) meetings for governance of patient safety
- Invite all types of health professionals to M&M meetings
and notify them in advance which cases are to be
reviewed and discussed.
- Employ a short, standardised review process that
highlights avoidable deaths and contributory factors,
allowing for staff involvement in the design and ﬂexibility
for specialty-speciﬁc questions as necessary.
- Allow adequate time for case discussions using the
review questions as an aid.
- Encourage a focus on systems and process variations
and not individual competence.
- Carry out the review openly, summarising actions at the
end of the meeting and tracking them at the following
one.
- Record meeting outcomes electronically to facilitate audit
and performance data.
- Integrate M&M meetings into the wider governance
structure and monitor meeting outcomes for shared
learning and assurance.
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Original researchout by individual senior clinicians. However, the larger
hospitals were beginning to see the need for a more
effective way of reviewing larger numbers of deaths and
the important role that M&M meetings could play, and
were introducing standard trust-wide review processes.
CONCLUSION
M&M meetings have the potential to contribute to the
governance of patient safety. They exist in many
healthcare organisations and are a governance resource
that is generally underutilised. They can improve the
accountability of mortality data and support quality
improvement without compromising professional
learning, especially when facilitated by a standardised
mortality review process.
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